Sanofi-Aventis Awards Euro RSCG Worldwide Drug Account
Nov 17, 2006, 7:00 AM
Sanofi-Aventis, the world's third-largest pharmaceutical company, has named Euro RSCG Worldwide its global agency in charge of all communications for Lovenox/Clexane, a leading product for thrombosis treatment, and Lantus and Apidra, which treat diabetes. This is the first global pharmaceutical client for the company. Sanofi-Aventis has enlarged its partnership with Euro RSCG Life by awarding the agency the responsibility of launching all communications programs for all new brands in these two therapeutic domains.